Apatinib-based neoadjuvant regimens show promise in resectable gastric cancer meta-analysis
A pooled analysis of 19 studies finds that neoadjuvant apatinib-based regimens achieve a 21 percent pathologic complete response rate in ...
A pooled analysis of 19 studies finds that neoadjuvant apatinib-based regimens achieve a 21 percent pathologic complete response rate in ...
A new meta-analysis of eight randomized trials finds that exercise during neoadjuvant chemotherapy did not improve pathologic complete response across ...
A prospective study finds that 68Ga-HER2 PET/CT scans after just two cycles of neoadjuvant therapy can predict which HER2-positive breast ...
Secondary results from the ECOG-ACRIN CompassHER2-pCR trial identify clinical and molecular factors, including HER2DX genomic scores, that predict which stage ...
A new meta-analysis of five observational studies finds that adding pembrolizumab to neoadjuvant chemotherapy in early-stage triple-negative breast cancer appears ...
A retrospective cohort study of 215 patients finds that small node-negative triple-negative breast cancers show similar biology and outcomes across ...
A national database analysis of 8,831 patients found that a Ki-67 proliferation index of 45.8 percent or higher more than ...
A new study shows that targeted axillary dissection delivers equivalent recurrence, survival, and mortality outcomes compared with full axillary lymph ...
For decades, women diagnosed with triple-negative breast cancer have faced one of the most demanding treatment journeys in oncology, typically ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine